|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
2 October 2017 |
|
Main ID: |
ChiCTR-IOR-17012621 |
|
Date of registration:
|
2017-09-08 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
penetrating method form Zhibian (BL54) to Shuidao (St28) with long needle for primary dysmenorhea: a randomized controlled trial
|
|
Scientific title:
|
penetrating method form Zhibian (BL54) to Shuidao (St28) with long needle for primary dysmenorhea: a randomized controlled trial |
|
Date of first enrolment:
|
2014-04-01 |
|
Target sample size:
|
treatment group:60;control group:60; |
|
Recruitment status: |
Completed |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=21480 |
|
Study type:
|
Interventional study |
|
Study design:
|
Randomized parallel controlled trial
|
|
Phase:
|
Other
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Laixi Ji
|
|
Address:
|
121 Daxue street, Higher Educaiton Area, Shanxi, China
|
|
Telephone:
|
+86 13509714277 |
|
Email:
|
tyjilaixi@126.com |
|
Affiliation:
|
Shanxi University of Chinese Medicine |
|
|
Name:
|
Haijun Wang
|
|
Address:
|
121 Daxue street, Higher Educaiton Area, Shanxi, China
|
|
Telephone:
|
+86 15803409395 |
|
Email:
|
whjdavid@163.com |
|
Affiliation:
|
Shanxi University of Chinese Medicine |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Aged from 18 to 35 years without history of delivery;
2. Normal menstrual cycle (28+/-7 days) during the last 3 months;
3. Diagnosed with PD according to the Primary Dysmenorrhea Consensus Guidelines;
4. Menstrual pain scored > 40 mm on the Visual Analog Scale (VAS);
5. Agree with all procedures in this trial by signing a written informed consent.
Exclusion criteria: 1. Secondary dysmenorrhea caused by gynecological problems confirmed by Obstetrician visit or gynecological abdominal ultrasound B examination;
2. Serious contraindications such as progressive central nervous disorder, AID, spsychiatric disorders, malignant hypertension, hematological diseases, hepatic insufficiency;
3. Having the disease of peptic ulcer;
4. Receiving or having received any other treatment for PD in the previous15days;
5. Having the allergic history to aspirin.
Age minimum:
18
Age maximum:
35
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
primary dysmenorrhea
|
|
Intervention(s)
|
|
treatment group:penetrating method form Zhibian (BL54) to Shuidao (St28);control group:ibuprofen capsules;
|
|
Primary Outcome(s)
|
|
Visual Analogue Scale;Cox Menstrual Symptom Scale;
|
|
Secondary Outcome(s)
|
|
Hemorheology;
|
|
Secondary ID(s)
|
|
AMCTR-IOR-17000101
|
|
Source(s) of Monetary Support
|
|
self-raised fund
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|